Ally Bridge Group (NY) LLC Quant / Systematic

Location: New York, NY

CIK: 0001822947 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 16, 2022

Total Value: $135M (100.0% shares, 0.0% debt)

Holdings (21)

LNTH LANTHEUS HLDGS INC 11.7%

Value $15.76M Shares 285,000 Est. Cost $26.60 Unrealized +41.1%

— IVERIC BIO INC 8.1%

Value $10.94M Shares 650,000 Est. Cost $16.55 Unrealized —

GH GUARDANT HEALTH INC 7.9%

Value $10.6M Shares 160,000 Est. Cost $91.40 Unrealized -25.1%

ARVN ARVINAS INC 7.5%

Value $10.1M Shares 150,000 Est. Cost $57.28 Unrealized +19.0%

COGT COGENT BIOSCIENCES INC 7.3%

Value $9.808M Shares 1,309,430 Est. Cost $10.99 Unrealized -36.6%

VRDN VIRIDIAN THERAPEUTICS INC 6.8%

Value $9.171M Shares 496,012 Est. Cost $18.20 Unrealized +5.6%

FATE FATE THERAPEUTICS INC 5.2%

Value $7.037M Shares 181,500 Est. Cost $63.35 Unrealized -38.9%

NUVB NUVATION BIO INC 4.4%

Value $5.981M Shares 1,137,152 Est. Cost $11.18 Unrealized -49.8%

— CEREVEL THERAPEUTICS HLDNG I 4.4%

Value $5.952M Shares 170,000 Est. Cost $35.01 Unrealized —

— SOMALOGIC INC 4.4%

Value $5.895M Shares 735,000 Est. Cost $12.39 Unrealized —

— ISOPLEXIS CORP 4.2%

Value $5.66M Shares 1,650,118 Est. Cost $9.19 Unrealized —

RPID RAPID MICRO BIOSYSTEMS INC 3.5%

Value $4.751M Shares 699,664 Est. Cost $15.69 Unrealized -53.1%

NAUT NAUTILUS BIOTECHNOLOGY INC 3.5%

Value $4.69M Shares 1,080,566 Est. Cost $10.83 Unrealized -62.1%

NTLA INTELLIA THERAPEUTICS INC 3.2%

Value $4.36M Shares 60,000 Est. Cost $36.31 Unrealized +133.3%

— SYROS PHARMACEUTICALS INC 3.0%

Value $4.004M Shares 3,364,895 Est. Cost $9.70 Unrealized —

GOSS GOSSAMER BIO INC 2.9%

Value $3.906M Shares 450,000 Est. Cost $8.67 Unrealized +11.2%

— JOUNCE THERAPEUTICS INC 2.8%

Value $3.735M Shares 550,000 Est. Cost $8.35 Unrealized —

STOK STOKE THERAPEUTICS INC 2.7%

Value $3.684M Shares 175,000 Est. Cost $23.86 Unrealized -16.1%

SGHT SIGHT SCIENCES INC 2.7%

Value $3.639M Shares 314,804 Est. Cost $32.87 Unrealized -53.2%

— MEDAVAIL HOLDINGS INC 2.1%

Value $2.836M Shares 2,920,780 Est. Cost $15.05 Unrealized —

— VERVE THERAPEUTICS INC 1.8%

Value $2.404M Shares 105,360 Est. Cost $38.25 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
LNTH	LANTHEUS HLDGS INC	285,000	$15.76M	11.7%	$26.60	+41.1%	COM	516544103
—	IVERIC BIO INC	650,000	$10.94M	8.1%	$16.55	—	COM	46583P102
GH	GUARDANT HEALTH INC	160,000	$10.6M	7.9%	$91.40	-25.1%	COM	40131M109
ARVN	ARVINAS INC	150,000	$10.1M	7.5%	$57.28	+19.0%	COM	04335A105
COGT	COGENT BIOSCIENCES INC	1,309,430	$9.808M	7.3%	$10.99	-36.6%	COM	19240Q201
VRDN	VIRIDIAN THERAPEUTICS INC	496,012	$9.171M	6.8%	$18.20	+5.6%	COM	92790C104
FATE	FATE THERAPEUTICS INC	181,500	$7.037M	5.2%	$63.35	-38.9%	COM	31189P102
NUVB	NUVATION BIO INC	1,137,152	$5.981M	4.4%	$11.18	-49.8%	COM CL A	67080N101
—	CEREVEL THERAPEUTICS HLDNG I	170,000	$5.952M	4.4%	$35.01	—	COM	15678U128
—	SOMALOGIC INC	735,000	$5.895M	4.4%	$12.39	—	CLASS A COM	83444K105
—	ISOPLEXIS CORP	1,650,118	$5.66M	4.2%	$9.19	—	COM	465005106
RPID	RAPID MICRO BIOSYSTEMS INC	699,664	$4.751M	3.5%	$15.69	-53.1%	CLASS A COM	75340L104
NAUT	NAUTILUS BIOTECHNOLOGY INC	1,080,566	$4.69M	3.5%	$10.83	-62.1%	COM	63909J108
NTLA	INTELLIA THERAPEUTICS INC	60,000	$4.36M	3.2%	$36.31	+133.3%	COM	45826J105
—	SYROS PHARMACEUTICALS INC	3,364,895	$4.004M	3.0%	$9.70	—	COM	87184Q107
GOSS	GOSSAMER BIO INC	450,000	$3.906M	2.9%	$8.67	+11.2%	COM	38341P102
—	JOUNCE THERAPEUTICS INC	550,000	$3.735M	2.8%	$8.35	—	COM	481116101
STOK	STOKE THERAPEUTICS INC	175,000	$3.684M	2.7%	$23.86	-16.1%	COM	86150R107
SGHT	SIGHT SCIENCES INC	314,804	$3.639M	2.7%	$32.87	-53.2%	COM	82657M105
—	MEDAVAIL HOLDINGS INC	2,920,780	$2.836M	2.1%	$15.05	—	COM	58406B103
—	VERVE THERAPEUTICS INC	105,360	$2.404M	1.8%	$38.25	—	COM	92539P101